Lantern Pharma LTRN Earnings Call Transcripts

NASDAQ LTRN
$0.57 +0.04 (+6.75%)
At close: Nov 6, 2026 · 4:00 PM EST
2 earnings calls on file for Lantern Pharma, from Q1 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Lantern Pharma Q2 2026 Earnings Call

Aug 14, 2026 5,995 words · 26 min read
  • Panna SharmaPresident and Chief Executive Officer
  • David R. MargraveChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Lantern Pharma Earnings Call Transcripts

Calls2
LatestAug 14, 2026
SinceQ1 2025

Fiscal 2026

Fiscal 2025

All 2 Lantern Pharma transcripts Register to get access to Lantern Pharma’s earnings call transcripts.